DAX25.278 +1,1%Est506.103 +1,4%MSCI World4.343 -0,1%Top 10 Crypto8,5500 -2,8%Nas22.754 +0,8%Bitcoin56.909 +0,9%Euro1,1801 +0,1%Öl70,52 +0,3%Gold5.019 +0,8%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Bayer BAY001 Rheinmetall 703000 Siemens Energy ENER6Y SAP 716460 NVIDIA 918422 Deutsche Telekom 555750 Infineon 623100 Amazon 906866 Siemens 723610 Lufthansa 823212 Microsoft 870747 BASF BASF11 RENK RENK73 DroneShield A2DMAA Mercedes-Benz Group (ex Daimler) 710000
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Nikkei im Plus -- Figma-Umsatz über Erwartungen -- eBay verdient mehr -- Airbus will mehr ausschütten
Top News
Airbus-Aktie dennoch tiefer: Prognose erfüllt - Dividende steigt Airbus-Aktie dennoch tiefer: Prognose erfüllt - Dividende steigt
eBay-Aktie freundlich: Gewinn und Umsatz übertreffen Analystenerwartungen eBay-Aktie freundlich: Gewinn und Umsatz übertreffen Analystenerwartungen
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Orexo A Aktie

Kaufen
Verkaufen
2,42 EUR +0,03 EUR +1,26 %
FSE
26,30 SEK +0,30 SEK +1,15 %
STO
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.84,20 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA0HG6G

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINSE0000736415

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolORXOF

Orexo A Aktien News

DatumMeistgelesen
PR NewswireNotice of Annual General Meeting of Orexo
PR NewswireNotice of Annual General Meeting of Orexo
PR NewswireOrexo successfully issues senior secured callable floating rate social bonds of SEK 500 m and announces results of the tender offer for its existing bonds
PR NewswireOrexo successfully issues senior secured callable floating rate social bonds of SEK 500 m and announces results of the tender offer for its existing bonds
PR NewswireOrexo strengthens its sustainability work by establishing a social financing framework
PR NewswireOrexo and Sobi agree to advance feasibility study with AmorphOX
PR NewswireOrexo and Sobi agree to advance feasibility study with AmorphOX
PR NewswireOrexo Interim Report Q4 2023, incl. Full Year Report
PR NewswireOrexo Interim Report Q4 2023, incl. Full Year Report
PR NewswireOrexo's OX640 development results to be presented at the 2024 AAAAI Annual Meeting in Washington, DC
PR NewswireOrexo's OX640 development results to be presented at the 2024 AAAAI Annual Meeting in Washington, DC
PR NewswireOrexo announces FDA acceptance of New Drug Application filing for OX124, a high-dose rescue medication for opioid overdose
PR NewswireOrexo announces FDA acceptance of New Drug Application filing for OX124, a high-dose rescue medication for opioid overdose
PR NewswireOrexo Q3 2023 Interim Report
PR NewswireOrexo announces changes in the company´s Board of Directors
PR NewswireOrexo announces changes in the company´s Board of Directors
PR NewswireOrexo´s Nomination Committee for the Annual General Meeting 2024
PR NewswireOrexo´s Nomination Committee for the Annual General Meeting 2024
PR NewswireReport from Orexo´s extraordinary general meeting
PR NewswireReport from Orexo´s extraordinary general meeting
PR NewswireOrexo announces data from the MODIA® study evaluating impact on use of illicit opioids
PR NewswireOrexo announces data from the MODIA® study evaluating impact on use of illicit opioids
PR NewswireNotice of Extraordinary General Meeting in Orexo AB (publ)
PR NewswireOrexo submits New Drug Application to FDA for OX124, a high-dose rescue medication for opioid overdose
PR NewswireOrexo submits New Drug Application to FDA for OX124, a high-dose rescue medication for opioid overdose
PR NewswireOrexo to participate in Pareto Securities´ 14th Annual Healthcare Conference 2023
PR NewswireOrexo to participate in Pareto Securities´ 14th Annual Healthcare Conference 2023
PR NewswireOrexo secures patent protection in the US for OX640, a nasal epinephrine powder product
PR NewswireOrexo secures patent protection in the US for OX640, a nasal epinephrine powder product
PR NewswireOrexo's patent win for ZUBSOLV® appealed
PR NewswireOrexo's patent win for ZUBSOLV® appealed
PR NewswireOrexo Q2 2023 Interim Report
PR NewswireOrexo Q2 2023 Interim Report
PR NewswireOrexo wins patent litigation for ZUBSOLV® in the US
PR NewswireOrexo wins patent litigation for ZUBSOLV® in the US
PR NewswireOrexo Interim Report Q1 2023
PR NewswireReport from Orexo AB's annual general meeting
PR NewswireReport from Orexo AB's annual general meeting
PR NewswireOrexo shares new timeline for the high-dose rescue medication for opioid overdose, OX124
PR NewswireOrexo shares new timeline for the high-dose rescue medication for opioid overdose, OX124

Orexo A News

Orexo A News: auf dieser Seite finden Sie alle Orexo A News und Nachrichten zur Orexo A Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Orexo A News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Orexo A News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.